Serum and follicular fluid levels of soluble Fas, soluble Fas ligand and apoptosis of luteinized granulosa cells in PCOS patients undergoing IVF

Human Reproduction

Volumn 20, Issue 9, 2005, Pages 2391-2395

  Onalan, Gogsen ^b   Selam, Belgin ^a   Baran, Yusuf ^c   Cincik, Mehmet ^d   Onalan, Reside ^f   Gündüz, Ufuk ^c   Ural, Ali Ugur ^e   Pabuccu, Recai ^d  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b Centrum Clinic   (Turkey)

^c MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^d Department of Obstetrics and Gynecology   (Turkey)

^e GULHANE SCHOOL OF MEDICINE   (Turkey)

^f Zekai Tahir Burak Women's Health Training and Education Hospital   (Turkey)

Author keywords

Apoptosis; IVF; Metformin; PCOS; sFas

Indexed keywords

AGAROSE; CELL DNA; CHORIONIC GONADOTROPIN; DNA FRAGMENT; FAS ANTIGEN; FAS LIGAND; GONADORELIN AGONIST; METFORMIN; PLACEBO; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ADULT; APOPTOSIS; ARTICLE; CELL PROTECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; GRANULOSA CELL; HUMAN; INFERTILITY; INTRACYTOPLASMIC SPERM INJECTION; LUTEINIZATION; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

EID: 24044552671     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/dei068     Document Type: Article

References (28)

1. Barak V, Mordel N, Zajicek G, Kalichman I, Treves AJ and Laufer N (1992) The correlation between interleukin 2 and soluble interleukin 2 receptors to oestradiol, progesterone and testosterone levels in periovulatory follicles of in-vitro fertilization patients. Hum Reprod 7,926-929.
2. Cataldo NA, Dumesic DA, Goldsmith PC and Jaffe RB (2000) Immunolocalization of Fas and Fas ligand in the ovaries of women with polycystic ovary syndrome: Relationship to apoptosis. Hum Reprod 15,1889-1897.
3. Crave JC, Fimbel S, Lejeune H, Cugnardey N, Dechaud H and Pugeat M (1995) Effects of diet and metformin administration on sex hormonebinding globulin, androgens, and insulin in hirsute and obese women. J Clin Endocrinol Metab 80,2057-2062.
4. Dunaif A, Segal KR, Futterweit W and Dobrjansky A (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38,1165-1174.
5. Dunn CJ and Peters DH (1995) Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs 49,721-749.
6. Fedorcsak P, Dale PO, Storeng R, Abyholm T and Tanbo T (2003) The effect of metformin on ovarian stimulation and in vitro fertilisation in insulin resistant women with polycystic ovary syndrome: An open-label randomised cross-over trial. Gynecol Endocrinol 17,207-214.
7. Ferriman D and Gallway JD. (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol and Metab 21,1440-1448.
8. Homburg R (1998) Involvement of growth factors in the pathophysiology of polycystic ovary syndrome. Gynecol Endocrinol 12,391-397.
9. Homburg R (2002) Should patients with polycystic ovarian syndrome be treated with metformin? A note of cautious optimism. Hum Reprod 17,853-856.
10. Hwang JL, Seow KM, Lin YH, Hsieh BC, Huang LW, Chen HJ, Huang SC, Chen CY, Chen PH and Tzeng CR (2005) IVF versus ICSI in sibling oocytes from patients with polycystic ovarian syndrome: A randomized controlled trial. Hum Reprod, in press.
11. Jonard S and Dewailly D (2004) The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 10,107-117.
12. Jose de los Santos M, Anderson DJ, Racowsky C and Hill JA (2000) Presence of Fas-Fas ligand system and bcl-2 gene products in cells and fluids from gonadotropin-stimulated human ovaries. Biol Reprod 63,1811-1816.
13. Kaipia A and Hsueh AJ (1997) Regulation of ovarian follicle atresia. Annu Rev Physiol 59,349-363.
14. Kefas BA, Cai Y, Kerckhofs K, Ling Z, Martens G, Heimberg H, Pipeleers D and Van de Casteele M (2004) Metformin-induced stimulation of AMP-activated protein kinase in beta-cells impairs their glucose responsiveness and can lead to apoptosis. Biochem Pharmacol 68,409-416.
15. Kjotrod SB, von During V and Carlsen SM (2004) Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study. Hum Reprod 19,1315-1322.
16. Lambert-Messerlian G, Taylor A, Leykin L, Isaacson K, Toth T, Chang Y and Schneyer A (1997) Characterization of intrafollicular steroid hormones, inhibin, and follistatin in women with and without polycystic ovarian syndrome following gonadotropin hyperstimulation. Biol Reprod 57,1211-1216.
17. Mikkelsen AL, Host E and Lindenberg S (2001) Incidence of apoptosis in granulosa cells from immature human follicles. Reproduction 122, 481-486.
18. Onalan G, Pabuçcu R, Goktolga U, Ceyhan T, Bagis T and C1nc1k M (2005) Metformin treatment in patients with PCOS undergoing in vitro fertilization: A prospective randomized trial. Fertil Steril, in press.
19. Orvieto R, Voliovitch I, Fishman P and Ben-Rafael Z (1995) Interleukin-2 and ovarian hyperstimulation syndrome: A pilot study. Hum Reprod 10, 24-27.
20. Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19, 41-47.
21. Sanbrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
22. Sarandakou A, Malamitsi-Puchner A, Baka S, Rizos D, Hassiakos D and Creatsas G (2003) Apoptosis and proliferation factors in serum and follicular fluid from women undergoing in vitro fertilization. Fertil Steril 79,634-636.
23. Srivastava, MLJ, Fichorova R, De los Santos and Anderson DJ (1998) Soluble Fas (sFas) and soluble Fas ligand (sFasL) in human reproductive tract fluids. Proceedings of the 45th Annual Meeting of the Society for Gynecologic Investigation, Chicago, IL 1998 Abstract T203.
24. Stadtmauer LA, Toma SK, Riehl RM and Talbert LM (2001) Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors. Fertil Steril 75,505-509.
25. Stadtmauer LA, Wong BC and Oehninger S (2002) Should patients with polycystic ovary syndrome be treated with metformin? Benefits of insulin sensitizing drugs in polycystic ovary syndrome - beyond ovulation induction. Hum Reprod 17,3016-3026.
26. Ueno T, Toi M and Tominaga T (1999) Circulating soluble Fas concentration in breast cancer patients. Clin Cancer Res 5,3529-3533.
27. Webber LJ, Stubbs S, Stark J, Trew GH, Margara R, Hardy K and Franks S (2003) Formation and early development of follicles in the polycystic ovary. Lancet 362,1017-1021.
28. Yuan W and Giudice LC (1997) Programmed cell death in human ovary is a function of follicle and corpus luteum status. J Clin Endocrinol Metab 82,3148-3155.